SPOTLIGHT: Is the NHS really cutting drug spending by 10%?

U.K. officials are pooh-poohing reports that they intend to cut drug spending by 10 percent with a new pharma contract now under negotiation. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.